Uhlinger C, Kristula M
Department of Food Animal and Equine Medicine, College of Veterinary Medicine, North Carolina State University, Raleigh 27606.
J Am Vet Med Assoc. 1992 Jul 1;201(1):51-5.
Anthelmintic schedules that alternate between drug classes are widely used in horses. However, the results of investigations in which ovine nematode parasites were used have established that alternation of drug classes does not delay the development of drug resistance. This field study was designed to assess the effect of alternation of drug classes on the development of oxibendazole (OBZ) resistance in benzimidazole (BZD)-resistant equine small strongyles. A privately owned herd of horses was used for this study. These animals grazed the same pasture and had been treated with the same anthelmintic schedule for several years. Prior studies had determined that the animals were parasitized with BZD-resistant small strongyles. The herd was divided into 2 groups of 20 and 21 horses. Group-1 horses were given OBZ 6 times a year and had a total of 25 treatments with the drug. Group-2 horses were given OBZ 3 times a year, in alternation with non-BZD drugs, and had a total of 16 treatments. Statistical analysis revealed no difference between groups for the change in pretreatment fecal egg count following treatments 1, 4, 7, 10, 13, and 16. Alternation of drug classes did not effect the development of drug resistance in this trial. The efficacy of OBZ decreased with repeated treatments with the drug. By treatment 13, the efficacy, as evaluated by the fecal egg count reduction test, had decreased to less than 70% in both groups.
在马匹中,交替使用不同药物类别的驱虫方案被广泛应用。然而,使用绵羊线虫寄生虫进行的调查结果表明,药物类别交替并不能延缓耐药性的发展。本田间研究旨在评估药物类别交替对苯并咪唑(BZD)耐药的马小型圆线虫对奥昔苯达唑(OBZ)耐药性发展的影响。本研究使用了一群私人拥有的马匹。这些动物在同一牧场放牧,并且多年来一直采用相同的驱虫方案进行治疗。先前的研究已确定这些动物感染了对BZD耐药的小型圆线虫。该马群被分为两组,一组20匹马,另一组21匹马。第1组马匹每年给予OBZ 6次,总共使用该药物进行25次治疗。第2组马匹每年给予OBZ 3次,与非BZD药物交替使用,总共进行16次治疗。统计分析显示,在第1、4、7、10、13和16次治疗后,两组在治疗前粪便虫卵计数的变化方面没有差异。在本试验中,药物类别交替并未影响耐药性的发展。随着OBZ重复治疗,其疗效下降。到第13次治疗时,通过粪便虫卵计数减少试验评估,两组的疗效均降至70%以下。